Vascular and renal hemodynamic changes after renal denervation

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 7, 2013, Pages 1195-1201

  Ott, Christian ^a   Janka, Rolf ^a   Schmid, Axel ^a   Titze, Stephanie ^a   Ditting, Tilmann ^a   Sobotka, Paul A ^b,c   Veelken, Roland ^a   Uder, Michael ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c Coridea NC1 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CREATININE; CYSTATIN C; HEPARIN; NARCOTIC AGENT;

ADULT; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OPEN STUDY; PROSPECTIVE STUDY; PULSE WAVE; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; SPIN LABELING; SYMPATHETIC TONE; VISCERAL PAIN;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; KIDNEY; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RENAL CIRCULATION; SYMPATHECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879947581     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08500812     Document Type: Article

References (40)

1. Symplicity HTN-1 Investigators: Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension 57: 911-917, 2011.
2. DiBona GF: Physiology in perspective: TheWisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289: R633-R641, 2005.
3. Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE: Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 25: 1126-1133, 2010.
4. Schneider MP, Janka R, Ziegler T, Raff U, Ritt M, Ott C, Veelken R, Uder M, Schmieder RE: Reversibility of the effects of aliskiren in the renal versus systemic circulation. Clin J Am Soc Nephrol 7: 258-264, 2012.
5. Campese VM, Kogosov E: Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25: 878-882, 1995.
6. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev 77: 75-197, 1997.
7. Esler M: The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: The transition from mechanisms to medical management. J Appl Physiol 108: 227-237, 2010.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572, 2003.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL; The task force for the management of arterial hypertension of the European Society of Hypertension; The task force for the management of arterial hypertension of the European Society of Cardiology: The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C: 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536, 2007.
10. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A; European Society of Hypertension: Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 27: 2121-2158, 2009.
11. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C: ESH position paper: renal denervation-an interventional therapy of resistant hypertension. J Hypertens 30: 837-841, 2012.
12. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M: Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-1281, 2009.
13. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M; Symplicity HTN-2 Investigators: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 376: 1903-1909, 2010.
14. Artz NS, Sadowski EA, Wentland AL, Djamali A, Grist TM, Seo S, Fain SB: Reproducibility of renal perfusion MR imaging in native and transplanted kidneys using non-contrast arterial spin labeling. J Magn Reson Imaging 33: 1414-1421, 2011.
15. Ott C, Haetinger S, Schneider MP, Pauschinger M, Schmieder RE: Comparison of two noninvasive devices for measurement of central systolic blood pressure with invasive measurement during cardiac catheterization. J Clin Hypertens (Greenwich) 14: 575-579, 2012.
16. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP: An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14: 160-167, 1993.
17. Pauca AL, O'Rourke MF, Kon ND: Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38: 932-937, 2001.
18. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16: 2079-2084, 1998.
19. Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME: Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension 42: 150-155, 2003.
20. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH: Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension 47: 1203-1208, 2006.
21. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976.
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Using standardized serumcreatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006.
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009.
24. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J; National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group: Preserving renal function in adults with hypertension and diabetes: a consensus approach. AmJ KidneyDis 36: 646-661, 2000.
25. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R, Mancia G: Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57: 846-851, 2011.
26. Petidis K, Anyfanti P, Doumas M: Renal sympathetic denervation: Renal function concerns. Hypertension 58: e19; author reply e20, 2011.
27. Kirchheim H, Ehmke H, Persson P: Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 67: 858-864, 1989.
28. Kon V: Neural control of renal circulation. Miner Electrolyte Metab 15: 33-43, 1989.
29. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD: Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361: 932-934, 2009.
30. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M: Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60: 419-424, 2012.
31. Velázquez H: Thiazide diuretics. Ren Physiol 10: 184-197, 1987.
32. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH: Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 29: 454-459, 2011.
33. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 50: 197-203, 2007.
34. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH: Central or peripheral systolic or pulse pressure: Which best relates to target organs and future mortality? J Hypertens 27: 461-467, 2009.
35. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian CardiacOutcomes Trial Investigators; CAFE Steering Committee andWriting Committee: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113: 1213-1225, 2006.
36. London GM, Asmar RG, O'Rourke MF, Safar ME; REASON Project Investigators: Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/ indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol 43: 92-99, 2004.
37. O'Rourke MF, Hayward CS: The pulse of cardiology: Quo vadis? J Am Coll Cardiol 54: 714-717, 2009.
38. Cecelja M, Jiang B, McNeill K, Kato B, Ritter J, Spector T, Chowienczyk P: Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: A twin study. J Am Coll Cardiol 54: 695-703, 2009.
39. Stella A, Zanchetti A: Functional role of renal afferents. Physiol Rev 71: 659-682, 1991.
40. Katholi RE: Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol 245: F1-F14, 1983